Stay updated on Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial

Sign up to get notified when there's something new on the Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page's revision history now lists v3.5.3 as the current revision, replacing the previous v3.5.2 entry; this reflects a new update to the study record.
    Difference
    0.1%
    Check dated 2026-04-30T15:55:49.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2 in the site metadata.
    Difference
    0.1%
    Check dated 2026-04-16T10:51:53.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Added B-cell chronic lymphocytic leukemia as a keyword/condition term and included Genetic and Rare Diseases Information Center as a resources entry. These updates improve searchability and provide readers with additional background information.
    Difference
    0.2%
    Check dated 2026-04-02T00:32:32.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page's revision history now shows the addition of v3.5.0 and the removal of v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-25T20:54:51.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T14:43:51.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. The prior funding-status notice and Revision: v3.4.1 were removed.
    Difference
    0.5%
    Check dated 2026-02-11T02:43:18.000Z thumbnail image

Stay in the know with updates to Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial page.